DNCB-BLM treatment increased B cell-dependent production of total IgE in serum by approximately twofold compared to that in normal mice, albeit without statistical significance; this finding correlates with the observation of increased B220+CD23+ B cells in the ALN of mice that received both DNCB and BLM. This evidence concerns the gene FCER2 and Bloom syndrome.